Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kirkpatrick, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, VHC; van Coevorden, F; van Geel, AN; Ezzat, A; Santoro, A; Oosterhuis, JW; van Glabbeke, M; Kirkpatrick, A; Verweij, J
      A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

      EUROPEAN JOURNAL OF CANCER
    2. Yamada, I; Matsuo, J; Toyoda, N; Kirkpatrick, A
      Materials processing by gas cluster ion beams

      MATERIALS SCIENCE & ENGINEERING R-REPORTS
    3. Kirkpatrick, A; Harris, DC; Johnson, LF
      Effect of ion implantation on the strength of sapphire at 300-600 degrees C

      JOURNAL OF MATERIALS SCIENCE
    4. Murdoch, JB; Weeks, JF; Howe, K; Smith, J; Kirkpatrick, A; McCrum, A
      The surgical management of cervical carcinoma within the South West of England: progress through an audit loop

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    5. Smith, DB; Oakley, D; Williams, E; Kirkpatrick, A
      Broadcast spray deposits from fan nozzles

      APPLIED ENGINEERING IN AGRICULTURE
    6. Postmus, PE; Haaxma-Reiche, H; Smit, EF; Groen, HJM; Karnicka, H; Lewinski, T; van Meerbeeck, J; Clerico, M; Gregor, A; Curran, D; Sahmoud, T; Kirkpatrick, A; Giaccone, G
      Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of theEuropean Organization for the Research and Treatment of Cancer Lung CancerCooperative Group

      JOURNAL OF CLINICAL ONCOLOGY
    7. Beck, K; Chan, VC; Shenoy, N; Kirkpatrick, A; Ramshaw, JAM; Brodsky, B
      Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Persikov, AV; Ramshaw, JAM; Kirkpatrick, A; Brodsky, B
      Amino acid propensities for the collagen triple-helix

      BIOCHEMISTRY
    9. Voute, PA; Souhami, RL; Nooij, M; Somers, R; Cortes-Funes, H; van der Eijken, JW; Pringle, J; Hogendoorn, PCW; Kirkpatrick, A; Uscinska, BM; van Glabbeke, M; Machin, D; Weeden, S
      A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma

      ANNALS OF ONCOLOGY
    10. Rivett, DE; Hewish, D; Kirkpatrick, A; Werkmeister, J
      Inhibition of membrane-active peptides by fatty acid-peptide hybrids

      JOURNAL OF PROTEIN CHEMISTRY
    11. Curtain, C; Separovic, F; Nielsen, K; Craik, D; Zhong, Y; Kirkpatrick, A
      The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids

      EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
    12. Shah, NK; Brodsky, B; Kirkpatrick, A; Ramshaw, JAM
      Structural consequences of D-amino acids in collagen triple-helical peptides

      BIOPOLYMERS
    13. SILBURN KA; MCPHEE DA; MAERZ AL; POUMBOURIOS P; WHITTAKER RG; KIRKPATRICK A; REILLY WG; MANTHEY MK; CURTAIN CC
      EFFICACY OF FUSION PEPTIDE HOMOLOGS IN BLOCKING CELL-LYSIS AND HIV-INDUCED FUSION

      AIDS research and human retroviruses
    14. POSTMUS PE; HAAXMAREICHE H; GREGOR A; GROEN HJM; LEWINSKI T; SCOLARD T; KIRKPATRICK A; CURRAN D; SAHMOUD T; GIACCONE G
      BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY

      Radiotherapy and oncology
    15. Nielsen, OS; Dombernowsky, P; Mouridsen, H; Crowther, D; Verweij, J; Buesa, J; Steward, W; Daugaard, S; van Glabbeke, M; Kirkpatrick, A; Tursz, T
      High-dose epirubicin is not an alternative to standard-dose doxorubicin inthe treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

      BRITISH JOURNAL OF CANCER
    16. SAHMOUD T; POSTMUS PE; VANPOTTELSBERGHE C; MATTSON K; TAMMILEHTO L; SPLINTER TAW; PLANTING AST; SUTEDJA T; VANPAWEL J; VANZANDWIJK N; BAAS P; ROOZENDAAL KJ; SCHRIJVER M; KIRKPATRICK A; VANGLABBEKE M; ARDIZZONI A; GIACCONE G
      ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP

      European journal of cancer
    17. VANZANDWIJK N; GROEN HJM; POSTMUS PE; BURGHOUTS JTW; TENVELDE GPM; ARDIZZONI A; SMITH IE; BAAS P; SAHMOUD T; KIRKPATRICK A; DALESIO O; GIACCONE G
      ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP

      European journal of cancer
    18. BLONDER L; HODES J; SCHMITT F; RANSEEN J; KIRKPATRICK A
      NEUROPSYCHOLOGICAL OUTCOME FOLLOWING GAMMA-KNIFE RADIOSURGERY FOR ARTERIOVENOUS-MALFORMATIONS

      Archives of clinical neuropsychology
    19. GREGOR A; DRINGS P; BURGHOUTS J; POSTMUS PE; MORGAN D; SAHMOUD T; KIRKPATRICK A; DALESIO O; GIACCONE G
      RANDOMIZED TRIAL OF ALTERNATING VERSUS SEQUENTIAL RADIOTHERAPY CHEMOTHERAPY IN LIMITED-DISEASE PATIENTS WITH SMALL-CELL LUNG-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LUNG-CANCER COOPERATIVE GROUP-STUDY/

      Journal of clinical oncology
    20. GLATTAUER V; WERKMEISTER JA; KIRKPATRICK A; RAMSHAW JAM
      IDENTIFICATION OF THE EPITOPE FOR A MONOCLONAL-ANTIBODY THAT BLOCKS PLATELET-AGGREGATION INDUCED BY TYPE-III COLLAGEN

      Biochemical journal
    21. MILLER RP; KIRKPATRICK A
      PROGNOSTIC VALUE OF PSYCHOLOGICAL-TESTING IN PATIENTS UNDERGOING SPINAL-CORD STIMULATION - A PROSPECTIVE-STUDY

      Neurosurgery
    22. SOUHAMI RL; CRAFT AW; VANDEREIJKEN JW; NOOIJ M; SPOONER D; BRAMWELL VHC; WIERZBICKI R; MALCOLM AJ; KIRKPATRICK A; USCINSKA BM; VANGLABBEKE M; MACHIN D
      RANDOMIZED TRIAL OF 2 REGIMENS OF CHEMOTHERAPY IN OPERABLE OSTEOSARCOMA - A STUDY OF THE EUROPEAN OSTEOSARCOMA INTERGROUP

      Lancet
    23. CHAN VC; RAMSHAW JAM; KIRKPATRICK A; BECK K; BRODSKY B
      POSITIONAL PREFERENCES OF IONIZABLE RESIDUES IN GLY-X-Y TRIPLETS OF THE COLLAGEN TRIPLE-HELIX

      The Journal of biological chemistry
    24. YANG W; CHAN VC; KIRKPATRICK A; RAMSHAW JAM; BRODSKY B
      GLY-PRO-ARG CONFERS STABILITY SIMILAR TO GLY-PRO-HYP IN THE COLLAGEN TRIPLE-HELIX OF HOST-GUEST PEPTIDES

      The Journal of biological chemistry
    25. SHAH NK; SHARMA M; KIRKPATRICK A; RAMSHAW JAM; BRODSKY B
      GLY-GLY-CONTAINING TRIPLETS OF LOW STABILITY ADJACENT TO A TYPE-III COLLAGEN EPITOPE

      Biochemistry
    26. POSTMUS PE; SCAGLIOTTI G; GROEN HJM; GOZZELINO F; BURGHOUTS JTW; CURRAN D; SAHMOUD T; KIRKPATRICK A; GIACCONE G; SPLINTER TAW
      STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL

      European journal of cancer
    27. BAGRIACIK EU; KIRKPATRICK A; MILLER KS
      GLYCOSYLATION OF NATIVE MHC CLASS IA MOLECULES IS REQUIRED FOR RECOGNITION BY ALLOGENEIC CYTOTOXIC T-LYMPHOCYTES

      Glycobiology
    28. VERWEIJ J; DEMULDER PHM; DEGRAEFF A; VERMORKEN JB; WILDIERS J; KERGER J; SCHORNAGEL J; COGNETTI F; KIRKPATRICK A; SAHMOUD T; LEFEBVRE JL
      PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK

      Annals of oncology
    29. PLANTING A; HELLE P; DRINGS P; DALESIO O; KIRKPATRICK A; MCVIE G; GIACCONE G
      A RANDOMIZED STUDY OF HIGH-DOSE SPLIT COURSE RADIOTHERAPY PRECEDED BYHIGH-DOSE CHEMOTHERAPY VERSUS HIGH-DOSE RADIOTHERAPY ONLY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER - AN EORTC LUNG-CANCER COOPERATIVEGROUP TRIAL

      Annals of oncology
    30. GIACCONE G; ARDIZZONI A; KIRKPATRICK A; CLERICO M; SAHMOUD T; VANZANDWIJK N
      CISPLATIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR LOCALLY ADVANCEDOR METASTATIC THYMOMA - A PHASE-II STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP

      Journal of clinical oncology
    31. SPLINTER TAW; SAHMOUD T; FESTEN J; VANZANDWIJK N; SORENSON S; CLERICO M; BURGHOUTS J; DAUTZENBERG B; KHO GS; KIRKPATRICK A; GIACCONE G
      2 SCHEDULES OF TENIPOSIDE WITH OR WITHOUT CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP

      Journal of clinical oncology
    32. KIRKPATRICK A
      TOPIC, COMMENT OR MODIFIER, MODIFIED - INFORMATION-STRUCTURE IN MODERN STANDARD CHINESE

      Studies in language
    33. HEWISH D; WERKMEISTER J; KIRKPATRICK A; CURTAIN C; PANTELA G; RIVETT DE
      PEPTIDE INHIBITORS OF MELITTIN ACTION

      Journal of protein chemistry
    34. RIVETT DE; KIRKPATRICK A; HEWISH DR; REILLY W; WERKMEISTER JA
      DIMERIZATION OF TRUNCATED MELITTIN ANALOGS RESULTS IN CYTOLYTIC PEPTIDES

      Biochemical journal
    35. SHAH N; RAMSHAW JAM; KIRKPATRICK A; SHAH C; BRODSKY B
      HOST-GUEST SET OF TRIPLE-HELICAL PEPTIDES

      Biophysical journal
    36. SHAH NK; RAMSHAW JAM; KIRKPATRICK A; SHAH C; BRODSKY B
      A HOST-GUEST SET OF TRIPLE-HELICAL PEPTIDES - STABILITY OF GLY-X-Y TRIPLETS CONTAINING COMMON NONPOLAR RESIDUES

      Biochemistry
    37. CASAGRANDA F; DUGGAN BM; KIRKPATRICK A; LASLETT RL; WILSHIRE JFK
      STUDIES IN THIOHYDANTOIN CHEMISTRY .2. C-TERMINAL SEQUENCING OF PEPTIDES

      Australian Journal of Chemistry
    38. LEFEBVRE JL; CHEVALIER D; LUBOINSKI B; KIRKPATRICK A; COLLETTE L; SAHMOUD T
      LARYNX PRESERVATION IN PYRIFORM SINUS CANCER - PRELIMINARY-RESULTS OFA EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PHASE-III TRIAL

      Journal of the National Cancer Institute
    39. MOBLEY PW; LEE HF; CURTAIN CC; KIRKPATRICK A; WARING AJ; GORDON LM
      THE AMINO-TERMINAL PEPTIDE OF HIV-1 GLYCOPROTEIN-41 FUSES HUMAN ERYTHROCYTES

      Biochimica et biophysica acta. Molecular basis of disease
    40. GREGOR A; DRINGS P; RINALDI M; SCHUSTER L; BURGHOUTS J; POSTMUS PE; DALESIO O; KIRKPATRICK A; BOES GH; VANZANDWIJK N
      ACUTE TOXICITY OF ALTERNATING SCHEDULE OF CHEMOTHERAPY AND IRRADIATION IN LIMITED SMALL-CELL LUNG-CANCER IN A PILOT-STUDY (08877) OF THE EORTC LUNG-CANCER COOPERATIVE GROUP

      Annals of oncology
    41. GORDON LM; WARING AJ; CURTAIN CC; KIRKPATRICK A; LEUNG C; FAULL K; MOBLEY PW
      ANTIVIRALS THAT TARGET THE AMINO-TERMINAL DOMAIN OF HIV TYPE-1 GLYCOPROTEIN-41

      AIDS research and human retroviruses
    42. SANTORO A; TURSZ T; MOURIDSEN H; VERWEIJ J; STEWARD W; SOMERS R; BUESA J; CASALI P; SPOONER D; RANKIN E; KIRKPATRICK A; VANGLABBEKE M; VANOOSTEROM A
      DOXORUBICIN VERSUS CYVADIC VERSUS DOXORUBICIN PLUS IFOSFAMIDE IN FIRST-LINE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED STUDYOF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER SOFT-TISSUEAND BONE SARCOMA GROUP

      Journal of clinical oncology
    43. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; DEGRAEFF A; CLAVEL M; SAHMOUD T; KIRKPATRICK A; LEFEBVRE JL
      RANDOMIZED PHASE-III TRIAL OF EDATREXATE VERSUS METHOTREXATE IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER HEAD AND NECK-CANCER COOPERATIVE GROUP-STUDY/

      Journal of clinical oncology
    44. POSTMUS PE; SMIT EF; HAAXMAREICHE H; VANZANDWIJK N; ARDIZZONI A; QUOIX E; KIRKPATRICK A; SAHMOUD T; GIACCONE G
      TENIPOSIDE FOR BRAIN METASTASES OF SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

      Journal of clinical oncology
    45. YAGHOUBI MA; KNAPPMILLER K; KIRKPATRICK A
      NUMERICAL PREDICTION OF CONTAMINANT TRANSPORT AND INDOOR AIR-QUALITY IN A VENTILATED OFFICE SPACE

      Particulate science and technology
    46. UNDERWOOD PA; BENNETT FA; KIRKPATRICK A; BEAN PA; MOSS BA
      EVIDENCE FOR THE LOCATION OF A BINDING SEQUENCE FOR THE ALPHA-2-BETA-1 INTEGRIN OF ENDOTHELIAL-CELLS, IN THE BETA-1 SUBUNIT OF LAMININ

      Biochemical journal
    47. MACREADIE IG; CASTELLI LA; HEWISH DR; KIRKPATRICK A; WARD AC; AZAD AA
      A DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR CONTAINING REPEATED H(S F)RIG AMINO-ACID MOTIFS CAUSES CELL-GROWTH ARREST AND STRUCTURAL DEFECTS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    48. CLAVEL M; VERMORKEN JB; COGNETTI F; CAPPELAERE P; DEMULDER PHM; SCHORNAGEL JH; TUENI EA; VERWEIJ J; WILDIERS J; CLERICO M; DALESIO O; KIRKPATRICK A; SNOW GB
      RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP

      Annals of oncology
    49. GORDON L; AZAD A; WARING A; MOBLEY P; SEPAROVIC F; RIVETT D; KIRKPATRICK A; CURTAIN C
      THE AMINO-TERMINAL REGION OF THE HIV-1 NEF PROTEIN IS FUSOGENIC AND CYTOLYTIC

      The FASEB journal
    50. CURTAIN CC; SEPAROVIC F; RIVETT D; KIRKPATRICK A; WARING AJ; GORDON LM; AZAD AA
      FUSOGENIC ACTIVITY OF AMINO-TERMINAL REGION OF HIV TYPE-1 NEF PROTEIN

      AIDS research and human retroviruses
    51. JARVIS JA; KIRKPATRICK A; CRAIK DJ
      H-1-NMR ANALYSIS OF FIBRIL-FORMING PEPTIDE-FRAGMENTS OF TRANSTHYRETIN

      International journal of peptide & protein research
    52. DEMULDER PHM; CAPPELAERE P; COGNETTI F; VERWEIJ J; SCHORNAGEL JH; VERMORKEN JB; KIRKPATRICK A; LEFEBVRE JL
      A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Cancer chemotherapy and pharmacology
    53. SCHAAKEKONING C; VANDENBOGAERT W; DALESIO O; FESTEN J; HOOGENHOUT J; VANHOUTTE P; KIRKPATRICK A; KOOLEN M; MAAT B; NIJS A; RENAUD A; RODRIGUS P; SCHUSTERUITTERHOEVE L; SCULIER J; VANZANDWIJK N; BARTELINK H
      RADIOSENSITIZATION BY CYTOTOXIC DRUGS - THE EORTC EXPERIENCE BY THE RADIOTHERAPY AND LUNG-CANCER COOPERATIVE GROUPS

      Lung cancer
    54. KIRKPATRICK A; DERASARI M; MILLER R; PATEL M
      PSYCHOGENIC MYOCLONUS

      Neurology
    55. VERMORKEN JB; VERWEIJ J; DEMULDER PHM; COGNETTI F; CLAVEL M; RODENHUIS S; KIRKPATRICK A; SNOW GB
      EPIRUBICIN IN PATIENTS WITH ADVANCED OR RECURRENT ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP

      Annals of oncology
    56. GORDON LM; CURTAIN CC; MCCLOYN V; KIRKPATRICK A; MOBLEY PW; WARING AJ
      THE AMINO-TERMINAL PEPTIDE OF HIV-1 GP41 INTERACTS WITH HUMAN SERUM-ALBUMIN

      AIDS research and human retroviruses
    57. GIACCONE G; DALESIO O; MCVIE GJ; KIRKPATRICK A; POSTMUS PE; BURGHOUTS JTM; BAKKER W; KOOLEN MGJ; VENDRIK CPJ; ROOZENDAAL KJ; PLANTING AST; VANZANDWIJK N; TENVELDE GJM; SPLINTER TAW
      MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - LONG-TERM RESULTS OF A RANDOMIZED TRIAL

      Journal of clinical oncology
    58. WERKMEISTER JA; KIRKPATRICK A; MCKENZIE JA; RIVETT DE
      THE EFFECT OF SEQUENCE VARIATIONS AND STRUCTURE ON THE CYTOLYTIC ACTIVITY OF MELITTIN PEPTIDES

      Biochimica et biophysica acta
    59. KALRA M; DERASARI M; WILSON M; GLODEK J; KIRKPATRICK A
      TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY WITH PERIACTIN

      Anesthesiology
    60. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; CLAVEL M; KIRKPATRICK A; LEFEBVRE JL
      A PHASE-II TRIAL OF 10-ETHYL-10-DEAZA-AMINOPTERIN, A NOVEL ANTIFOLATE, IN PATIENTS WITH ADVANCED AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 02:27:43